Lynn R Tanner (Lynn Tanner)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Childhood Cancer

Ejection Fraction

Acute Lymphoblastic Leukemia

Top Venues

Cancer reports (Hoboken, N.J.)

Pediatric blood & cancer

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) 7 (2) (2024)
Alex Hoover, Paige Reimche, Dave Watson, Lynn R Tanner, Laura Gilchrist, Mike Finch, Yoav H Messinger, Lucie M Turcotte
Healthcare cost and utilization for chimeric antigen receptor (CAR) T-cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis. Cancer reports (Hoboken, N.J.) (2024)
Lucie M Turcotte, David Watson, Lynn R Tanner, Alex Hoover, Laura Gilchrist, Mike Finch, Yoav H Messinger
Real-World Cost of Pediatric Acute Lymphoblastic Leukemia Care Among Commercially Insured Individuals in the United States: Effect of Era and Age at Diagnosis. JCO oncology practice 18 (11) (2022)
Lynn R Tanner, Susan Sencer, Nathan Gossai, David Watson, Mary C Hooke
CREATE Childhood Cancer Rehabilitation Program development: Increase access through interprofessional collaboration. Pediatric blood & cancer 69 (11) (2022)
Lynn R Tanner, Laura Gilchrist, Mary C Hooke, Susan Sencer
Comment on: Development of a comprehensive pediatric oncology rehabilitation program. Pediatric blood & cancer 67 (4) (2019)
Lynn R Tanner, Mary C Hooke
Improving body function and minimizing activity limitations in pediatric leukemia survivors: The lasting impact of the Stoplight Program. Pediatric blood & cancer 66 (5) (2019)